Sustained Virologic Response in People Who Inject Drugs and/or Who Are on Opioid Agonist Therapy: Is 90% Enough?
| dc.contributor.author | Naggie, Susanna | |
| dc.contributor.author | Ramers, Christian B | |
| dc.date.accessioned | 2023-03-02T15:10:16Z | |
| dc.date.available | 2023-03-02T15:10:16Z | |
| dc.date.issued | 2019-04 | |
| dc.date.updated | 2023-03-02T15:10:14Z | |
| dc.identifier | HEP41347 | |
| dc.identifier.issn | 2471-254X | |
| dc.identifier.issn | 2471-254X | |
| dc.identifier.uri | ||
| dc.language | eng | |
| dc.publisher | Ovid Technologies (Wolters Kluwer Health) | |
| dc.relation.ispartof | Hepatology communications | |
| dc.relation.isversionof | 10.1002/hep4.1347 | |
| dc.title | Sustained Virologic Response in People Who Inject Drugs and/or Who Are on Opioid Agonist Therapy: Is 90% Enough? | |
| dc.type | Journal article | |
| duke.contributor.orcid | Naggie, Susanna|0000-0001-7721-6975 | |
| pubs.begin-page | 453 | |
| pubs.end-page | 455 | |
| pubs.issue | 4 | |
| pubs.organisational-group | Duke | |
| pubs.organisational-group | School of Medicine | |
| pubs.organisational-group | Clinical Science Departments | |
| pubs.organisational-group | Institutes and Centers | |
| pubs.organisational-group | Medicine | |
| pubs.organisational-group | Medicine, Infectious Diseases | |
| pubs.organisational-group | Duke Clinical Research Institute | |
| pubs.publication-status | Published | |
| pubs.volume | 3 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Sustained Virologic Response in People Who Inject Drugs andor Who Are on Opioid Agonist Therapy Is 90% Enough.pdf
- Size:
- 83.13 KB
- Format:
- Adobe Portable Document Format